These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6996464)

  • 21. [Cell-mediated immunity induced experimentally by Serratia].
    Domínguez Rojas V; Fernández Criado C; Rey Calero J
    Rev Clin Esp; 1981 Nov; 163(3):185-8. PubMed ID: 7036255
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of immunological responsiveness and resistance to infection with Treponema pallidum in rabbits given immune lymphocyte preparations.
    Metzger M; Podwińska J; Smogór W
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):329-36. PubMed ID: 7447643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basics in practical applications and standardization of techniques of cellular immunology.
    Deodhar SD
    Lab Res Methods Biol Med; 1983; 8():71-8. PubMed ID: 6358747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca mulatta.
    Maddison SE; Hicklin MD; Conway BP; Kagan IG
    Science; 1972 Nov; 178(4062):757-9. PubMed ID: 4628344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer in vitro of tubercolin hypersensitivity by sensitised lymphocytes.
    Fazio M; Calabrese F; Giacomasso S; Negri L; Mastromatteo V
    Panminerva Med; 1993 Jun; 35(2):96-100. PubMed ID: 8414630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
    Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
    Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of the local transfer of cell-mediated immunity with dialyzable transfer factor.
    Gerbase-DeLima M; Carlquist I; Mendes NF
    Cell Immunol; 1979 Nov; 48(1):231-4. PubMed ID: 509535
    [No Abstract]   [Full Text] [Related]  

  • 29. Introduction of cellular immunity to a chemically altered tumor antigen.
    Chao HF; Peiper SC; Aach RD; Parker CW
    J Immunol; 1973 Dec; 111(6):1800-3. PubMed ID: 4750867
    [No Abstract]   [Full Text] [Related]  

  • 30. Transfer of tuberculin sensitivity by transfer factor in sarcoidosis.
    Horsmanheimo M; Virolainen M
    Clin Immunol Immunopathol; 1976 Sep; 6(2):231-7. PubMed ID: 963914
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on mechanisms of tuberculin hypersensitivity. I. The relation between the functions of cells mediating tuberculin-type hypersensitivity (TTH) and the infiltrating cells in skin reaction site (author's transl)].
    Oyamaguchi A
    Kekkaku; 1982 Feb; 57(2):59-71. PubMed ID: 7040775
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfer of cell-mediated immunity with cell-free leukocyte extracts. II. Demonstration of antigen-specific and nonspecific components.
    Croft S; Edwards JM; Basten A
    Cell Immunol; 1980 Dec; 56(2):427-39. PubMed ID: 6970628
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunopathogenesis of periodontal disease. Delayed hypersensitivity or polyclonal lymphocyte activation?].
    Valletta GC; Sbordone L
    Minerva Stomatol; 1981; 30(6):467-74. PubMed ID: 7035859
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transfer factor (TF) - a modulator of immunological activity].
    Grubek-Jaworska H; Komorowska-Rycerz A
    Postepy Hig Med Dosw; 1981; 35(6):549-74. PubMed ID: 6752921
    [No Abstract]   [Full Text] [Related]  

  • 35. Transfer factor and its protective effect against herpesvirus infections of marmosets.
    Eichberg JW; Heberling RL; Kalter SS; Steele RW; Kniker WT
    Primates Med; 1978; 10():271-6. PubMed ID: 205856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine transfer factors: dose-response relationships and routes of administration.
    Kirkpatrick CH; Hamad AR; Morton LC
    Cell Immunol; 1995 Sep; 164(2):203-6. PubMed ID: 7656328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of delayed cutaneous hypersensitivity with transfer factor.
    Kirkpatrick CH
    Cell Immunol; 1978 Nov; 41(1):62-71. PubMed ID: 719770
    [No Abstract]   [Full Text] [Related]  

  • 38. Bovine dialyzable lymph node extracts have antigen-dependent and antigen-independent effects on human cell-mediated immunity in vitro.
    Wilson GB; Newell RT; Burdash NM
    Cell Immunol; 1979 Sep; 47(1):1-18. PubMed ID: 315822
    [No Abstract]   [Full Text] [Related]  

  • 39. Human transfer factor activity in the guinea pig: absence of antigen specificity.
    Vandenbark AA; Burger DR; Vetto RM
    Clin Immunol Immunopathol; 1977 Jul; 8(1):7-16. PubMed ID: 69512
    [No Abstract]   [Full Text] [Related]  

  • 40. Atypical mycobacterium infection treated with dialyzable leukocyte extracts: evidence for antigenic specificity.
    Simon MR; Salberg DJ; Silva J; Ganji S; Desai S; Muller BF; Palutke M
    Clin Immunol Immunopathol; 1981 Jul; 20(1):123-8. PubMed ID: 6167387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.